7/29/2014 9:42:20 AM
Oxygen Biotherapeutics, Inc. (NASDAQ: OXBT) a specialty pharmaceutical company focused on developing and commercializing a portfolio of products for the critical care market, today announced financial results for the fiscal year ended April 30, 2014, and provided a corporate update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by